Company Email Format Management

Cartesian Therapeutics

Biotechnology Research Frederick, Maryland, United States 85 employees

Employees: 85
Contacts: 3
Emails: 3
Phones: 1

cartesiantherapeutics.com LinkedIn Crunchbase

Cartesian Therapeutics Overview

Headquarters: Frederick, Maryland, United States
Website: cartesiantherapeutics.com
Industry: Biotechnology Research
Employees: 85
Founded: 2016
Funding: 130.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Immunotherapy Oncology Molecular Biology Immunology Myasthenia Gravis ARDS Cell Therapy NETs Gene Therapy Cancer Research multiple myeloma SLE

About Cartesian Therapeutics

Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a potential first-in-class mRNA CAR-T in Phase 2b clinical development for patients with generalized myasthenia gravis and Phase 2 development for systematic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. The Company’s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA mRNA CAR-T. For more information, please visit www.cartesiantherapeutics.com

Cartesian Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Cartesian Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Rachel Duncan		Greater Boston, United States	Email
Cindy Douglas	Executive Office Administration Manager	New Market, Maryland, United States	Email
Christopher M. Jewell	Chief Scientific Officer, Cartesian Therapeutics - Institute Professor of Translational Engineering - Biotechnology Consultant	Washington Dc-baltimore Area, United States	View
Heng Xu	Research Scientist at Cartesian Therapeutics	Germantown, Maryland, United States	Email Phone